Taylor DN - Search Results

1

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.

Kotloff KL, Losonsky GA, Nataro JP, Wasserman SS, Hale TL, Taylor DN, Newland JW, Sadoff JC, Formal SB, Levine MM. Kotloff KL, et al. Among authors: taylor dn. Vaccine. 1995 Apr;13(5):495-502. doi: 10.1016/0264-410x(94)00011-b. Vaccine. 1995. PMID: 7639017 Clinical Trial.

2

Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate.

McKenzie R, Venkatesan MM, Wolf MK, Islam D, Grahek S, Jones AM, Bloom A, Taylor DN, Hale TL, Bourgeois AL. McKenzie R, et al. Among authors: taylor dn. Vaccine. 2008 Jun 19;26(26):3291-6. doi: 10.1016/j.vaccine.2008.03.079. Epub 2008 Apr 16. Vaccine. 2008. PMID: 18468742 Clinical Trial.

3

Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults.

Kotloff KL, Taylor DN, Sztein MB, Wasserman SS, Losonsky GA, Nataro JP, Venkatesan M, Hartman A, Picking WD, Katz DE, Campbell JD, Levine MM, Hale TL. Kotloff KL, et al. Among authors: taylor dn. Infect Immun. 2002 Apr;70(4):2016-21. doi: 10.1128/IAI.70.4.2016-2021.2002. Infect Immun. 2002. PMID: 11895966 Free PMC article. Clinical Trial.

4

Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously.

Edelman R, Taylor DN, Wasserman SS, McClain JB, Cross AS, Sadoff JC, Que JU, Cryz SJ. Edelman R, et al. Among authors: taylor dn. Vaccine. 1994 Nov;12(14):1288-94. doi: 10.1016/s0264-410x(94)80054-4. Vaccine. 1994. PMID: 7856293 Clinical Trial.

5

Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2.

Taylor DN, Phillip DF, Zapor M, Trofa A, Van de Verg L, Hartman A, Bendiuk N, Newland JW, Formal SB, Sadoff JC, et al. Taylor DN, et al. Vaccine. 1994 May;12(6):565-8. doi: 10.1016/0264-410x(94)90318-2. Vaccine. 1994. PMID: 8036831 Clinical Trial.

6

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.

Kotloff KL, Nataro JP, Losonsky GA, Wasserman SS, Hale TL, Taylor DN, Sadoff JC, Levine MM. Kotloff KL, et al. Among authors: taylor dn. Vaccine. 1995 Nov;13(16):1488-94. doi: 10.1016/0264-410x(95)00102-7. Vaccine. 1995. PMID: 8578831 Clinical Trial.

7

Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.

Fries LF, Montemarano AD, Mallett CP, Taylor DN, Hale TL, Lowell GH. Fries LF, et al. Among authors: taylor dn. Infect Immun. 2001 Jul;69(7):4545-53. doi: 10.1128/IAI.69.7.4545-4553.2001. Infect Immun. 2001. PMID: 11401998 Free PMC article. Clinical Trial.

8

Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.

Tacket CO, Losonsky G, Taylor DN, Baron LS, Kopecko D, Cryz S, Levine MM. Tacket CO, et al. Among authors: taylor dn. J Infect Dis. 1991 Apr;163(4):901-4. doi: 10.1093/infdis/163.4.901. J Infect Dis. 1991. PMID: 2010645

9

Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.

Katz DE, Coster TS, Wolf MK, Trespalacios FC, Cohen D, Robins G, Hartman AB, Venkatesan MM, Taylor DN, Hale TL. Katz DE, et al. Among authors: taylor dn. Infect Immun. 2004 Feb;72(2):923-30. doi: 10.1128/IAI.72.2.923-930.2004. Infect Immun. 2004. PMID: 14742537 Free PMC article.

10

Comparative evaluation of the antibody in lymphocyte supernatant (ALS) and enzyme-linked immunospot (ELISPOT) assays for measuring mucosal immune responses to Shigella antigens.

Feller AJ, McKenzie R, Taylor DN, Woods CC, Grahek SL, Islam D, Venkatesan MM, Hale TL, Bourgeois AL. Feller AJ, et al. Among authors: taylor dn. Vaccine. 2011 Nov 3;29(47):8487-9. doi: 10.1016/j.vaccine.2011.09.030. Epub 2011 Sep 20. Vaccine. 2011. PMID: 21939714 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page